{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:31:15Z","timestamp":1790847075402,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.bbrc.2017.07.143","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T09:02:37Z","timestamp":1501059757000},"page":"681-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation"],"prefix":"10.1016","volume":"491","author":[{"given":"Jun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd T.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenton L.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai H.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Idler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith B.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Wilsbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Pappano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.07.143_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","article-title":"The NAD metabolome\u2013a key determinant of cancer cell biology","volume":"12","author":"Chiarugi","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2017.07.143_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2017.07.143_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0021-9258(18)64790-8","article-title":"Biosynthesis of diphospyridine nucleotide. II Enzymatic aspects","volume":"233","author":"Breiss","year":"1958","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.07.143_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbamcr.2010.02.007","article-title":"Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD+ synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3","volume":"1803","author":"Ishidoh","year":"2010","journal-title":"Biochimica Biophysica Acta"},{"key":"10.1016\/j.bbrc.2017.07.143_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as therapeutic strategy in cancer","volume":"151","author":"Sampath","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2017.07.143_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/1471-2407-10-677","article-title":"Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase","volume":"10","author":"Oleson","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2017.07.143_bib7","doi-asserted-by":"crossref","first-page":"e109366","DOI":"10.1371\/journal.pone.0109366","article-title":"Structural basis for resistance to diverse classes of NAMPT inhibitiors","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2017.07.143_bib8","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/MCB.00112-09","article-title":"The small molecular GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors","volume":"29","author":"Watson","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2017.07.143_bib9","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-16-0819","article-title":"Discovery and characterization of novel non-substrate and substrate NAMPT","author":"Wilsbacher","year":"2017","journal-title":"Inhib. Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2017.07.143_bib10","series-title":"AbbVie Inc., Assignee. NAMPT and Rock Inhibitors. United States Patent 9302989","author":"Curtin","year":"2016"},{"key":"10.1016\/j.bbrc.2017.07.143_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/cbic.201402023","article-title":"Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase","volume":"15","author":"Oh","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbrc.2017.07.143_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jb\/mvp152","article-title":"Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase","volume":"147","author":"Takahashi","year":"2010","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2017.07.143_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1593\/neo.131304","article-title":"Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618","volume":"15","author":"Xiao","year":"2013","journal-title":"Neoplasia"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17315012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17315012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:21:36Z","timestamp":1767734496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17315012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0006291X17315012"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.143","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}